CS
BDSX icon

Cannell & Spears’s Biodesix BDSX Stock Holding History

Cannell & Spears’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,279
Closed -$77.6K – 414
2025
Q3 		$77.6K Sell
10,279
-1
-0% -$8 ﹤0.01% 397
2025
Q2 		$58K Hold
10,280
– – ﹤0.01% 390
2025
Q1 		$129K Hold
10,280
– – ﹤0.01% 377
2024
Q4 		$315K Hold
10,280
– – 0.01% 332
2024
Q3 		$366K Hold
10,280
– – 0.01% 326
2024
Q2 		$315K Hold
10,280
– – 0.01% 303
2024
Q1 		$294K Buy
+10,280
New +$352K 0.01% 320

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Cannell & Spears's BDSX Position: Q4 2025 in Review

Cannell & Spears sold out of Biodesix (BDSX) in Q4 2025, closing a stake of 10,279 shares — an estimated $77.6K sold.

Cannell & Spears first reported a position in BDSX in Q1 2024 and held it in 7 quarters. The position peaked at $366K in Q3 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • Cannell & Spears reported no remaining Biodesix position as of Q4 2025 after selling out during the quarter.
  • Cannell & Spears sold 10,279 Biodesix shares in Q4 2025, an estimated $77.6K.
  • Cannell & Spears first reported a position in Biodesix in Q1 2024 and held it in 7 quarters.
  • Cannell & Spears's Biodesix position peaked at $366K in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on Cannell & Spears's 13F filing for Q4 2025, filed 17 Feb 2026.